Month: February 2025
-
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings ANN ARBOR, Mich., Feb. 4, 2025 – ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that the company will present clinical data and scientific research at the following first quarter meetings: Details of…